RxDoctor Payments Data

Kelsey Peterson

Physician Assistant · Norfolk, NENPI 1639658479

Payments from drug & device makers

$731in general payments, 2019–2025

Across 43 payments — averaging $16.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$92
  • Bayer$80
  • Alkermes, Inc.$76
  • Gilead$63
  • Otsuka America Pharmaceutical, Inc.$57
  • Novo Nordisk$44
  • plus $318 from 16 others

What the payments were for

  • Food & beverage$731100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$731 in reported general payments places this provider in the 65th percentile of 1,127 physician assistant providers in Nebraska.

See all physician assistant providers in Nebraska

Medicare billing

Part B allowed, 2024
$1,293
Medicare patients
41
Services billed
120

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide54$71,798
EliquisApixaban38$33,364
OzempicSemaglutide19$28,701
FarxigaDapagliflozin Propanediol26$23,679
TrulicityDulaglutide20$21,449
Nucynta ErTapentadol Hcl12$14,835
KerendiaFinerenone11$11,892
Praluent PenAlirocumab22$11,457
Repatha SureclickEvolocumab18$9,815
MyrbetriqMirabegron14$7,347
Dexlansoprazole DrDexlansoprazole13$4,541
Lantus SolostarInsulin Glargine,hum.Rec.Anlog23$3,642
Novolog FlexpenInsulin Aspart12$2,790
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen100$1,982
Albuterol Sulfate HfaAlbuterol Sulfate68$1,849

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$29$93,24774 claims
Novo NordiskOzempic$44$28,70119 claims
AstraZenecaFarxiga$17$23,67926 claims
BayerKerendia$80$11,89211 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 1,127 physician assistant providers in Nebraska.

Other physician assistant in Norfolk

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →